ICE Bioscience
PrivateLast Round
Series B++
May 14, 2024
Total Funding Raised
$27.9M
Company Overview
ICE Bioscience operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B++ round in May 2024.
ICE Bioscience is a biotechnology company that operates as an integrated drug discovery contract research organization (CRO). The company provides services including target identification and validation, lead compound screening, and pre-clinical candidate selection for pharmaceutical and biotech partners.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ICE Bioscience Comparables
Compare ICE Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Domainex Ltd | 84% | |
| Reaction Biology Corporation | 84% | |
| Concept Life Sciences | 84% |
For institutional investors. Book with your work email.
ICE Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B++ | May 14, 2024 | ||||
| Series B Extension | Aug 1, 2023 | ||||
| Series B | Sep 26, 2022 | ||||
| Series A | May 14, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ICE Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series B Extension, Series B++ |
| Beijing E-Town International Investment & Development Co., Ltd. | Series B++ |
| Addor Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2025
Grew 24% QoQ, from 25 to 31 employees.
- Nov 27, 2024
Grew 47% QoQ, from 19 to 28 employees.
For institutional investors. Book with your work email.
ICE Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ICE Bioscience's valuation, stock price, and market status.
Is ICE Bioscience a public or private company?
ICE Bioscience is a private company.
What is the current stock price of ICE Bioscience?
ICE Bioscience is a private company, so its shares have no public market price. Caplight tracks ICE Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ICE Bioscience worth (valuation)?
Valuation information for ICE Bioscience is not publicly available.
Can I buy ICE Bioscience stock?
ICE Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ICE Bioscience's last funding round?
ICE Bioscience's most recent funding round was Series B++ on May 14, 2024.
Who are the main investors in ICE Bioscience?
Key investors in ICE Bioscience include Beijing E-Town International Investment & Development Co., Ltd..
Will ICE Bioscience IPO soon?
No public IPO plans have been announced for ICE Bioscience.
How can I track ICE Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in ICE Bioscience's shares on secondary markets.